Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

2 clinical studies listed.

Filters:

Chinese

Tundra lists 2 Chinese clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT07707466

Social Robots Empowering Patients

The purpose of this study is to evaluate whether a social robot can effectively support digital-literacy learning among low-income Chinese immigrants, particularly in the context of using the MyChart health portal. The study aims to understand whether robot-guided digital literacy education leads to improved engagement, comprehension, and confidence compared to a standard educational video.

Gender: All

Ages: 18 Years - Any

Updated: 2026-08-17

1 state

Healthy Adult
Chinese
RECRUITING

NCT07237750

iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss

Obesity and overweight are rising in Chinese populations, where metabolic risks begin at lower BMI thresholds than in Western cohorts. Many individuals with overweight or mild-to-moderate obesity are ineligible or unwilling to undergo bariatric surgery due to invasiveness and risk. Endoscopic bariatric and metabolic therapies offer minimally invasive alternatives but vary in complexity, cost, and safety profiles. Investigators developed a sutureless endoscopic procedure, Endoscopic Radial Compression Gastroplasty (ERCG), which reduces gastric volume by apposing gastric walls using a clip-and-loop system. This randomized controlled trial evaluates the efficacy and safety of ERCG versus an optimized lifestyle intervention in Asian adults with BMI 24.0-37.4 kg/m² who have not succeeded with conservative measures. Preliminary studies suggest ERCG can achieve approximately 12% total body weight loss (TBWL) at 3 months. The primary endpoint is percent TBWL at 3 months; secondary outcomes include changes in BMI, metabolic parameters, quality of life, and adverse events. Results are expected to inform the role of ERCG as a safe, effective, and scalable option between conservative care and bariatric surgery.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2026-03-13

1 state

Overweight and/or Obesity
Metabolic Syndrome
Nonalcoholic Fatty Liver Disease
+1